News
2hon MSN
Not long ago the largest company by market capitalization in Europe, the evolution of the weight loss medicine market has ...
Zepbound is the preferred weight loss medicine vs. Wegovy and has consistently beaten the latter in U.S. weekly prescriptions ...
This is just a tiny glimpse of the data available to CivicScience clients. Discover more data. CivicScience has data on more ...
6h
Zacks Investment Research on MSNHIMS Stock Dips Pre-Market Despite Q1 Earnings Beat, Gross Margin DownHims & Hers Health, Inc. HIMS delivered an earnings per share (EPS) of 20 cents in first-quarter 2025 compared with the ...
As weight loss medications, including Ozempic and WeGovy, have gained popularity across the U.S., they are not without side effects, some serious. According to a May 2024 CNN report, as many as 1 in 8 ...
Following the sell-off, Lilly trades at a forward price-to-earnings (P/E) of 37 times 2025 analyst estimates, with a price-to ...
From a technical perspective, FTAI Aviation (FTAI) is looking like an interesting pick, as it just reached a key level of support. FTAI recently overtook the 20-day moving average, and this suggests a ...
Three years since COVID-19 abated, UnitedHealth Group, CVS Health and other insurers are still feeling the hangover, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results